Related Experiment Video
Updated: Mar 28, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Coronary Microvascular Dysfunction, Microvascular Angina, and Management
Adrián I Löffler1, Jamieson M Bourque2
1Division of Cardiovascular Medicine, University of Virginia Health System, PO Box 800662, Charlottesville, VA, 22908, USA. al2ys@hscmail.mcc.virginia.edu.
Insights
Coronary microvascular dysfunction (CMD) indicates poor prognosis in patients with or without coronary artery disease (CAD). New noninvasive imaging techniques help identify microvascular angina (MVA), aiding risk stratification.
Area of Science:
- Cardiology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Coronary microvascular dysfunction (CMD) is increasingly recognized as a significant predictor of adverse outcomes in patients with and without obstructive epicardial coronary artery disease (CAD).
- Microvascular angina (MVA), resulting from CMD, presents clinically with chest pain that is often indistinguishable from angina caused by epicardial CAD.
- The historical diagnosis of cardiac syndrome X encompasses a heterogeneous group of patients, many of whom likely have underlying MVA.
Purpose of the Study:
- To review the diagnostic capabilities of emerging noninvasive imaging techniques for identifying CMD and MVA.
- To discuss the clinical implications of MVA in patients with and without obstructive CAD.
- To highlight the current limitations in understanding and treating MVA.
Main Methods:
- Review of recent analyses and literature on coronary microvascular dysfunction and microvascular angina.
- Discussion of noninvasive imaging modalities including stress positron-emission tomography (PET) and cardiovascular magnetic resonance (CMR) myocardial perfusion imaging.
- Analysis of patient populations previously categorized under cardiac syndrome X and those with persistent angina post-revascularization.
Main Results:
- Noninvasive imaging techniques like stress PET and CMR myocardial perfusion imaging enable improved identification of MVA.
- These tools allow differentiation of higher-risk from lower-risk patients within the MVA population, including those historically labeled as cardiac syndrome X.
- MVA can also be diagnosed in patients with obstructive epicardial CAD experiencing persistent angina after revascularization.
Conclusions:
- Emerging noninvasive imaging significantly enhances the diagnosis of microvascular angina (MVA).
- Improved diagnostic capabilities allow for better risk stratification in patients with MVA.
- Further research is needed to establish evidence-based treatment strategies and clarify the prognostic impact of MVA therapies.
Abstract:
Recent analyses have found that coronary microvascular dysfunction (CMD) portends a poor prognosis in patients with and without obstructive epicardial coronary artery disease (CAD). Chest pain in the absence of epicardial CAD is a common entity. Angina caused by CMD, microvascular angina (MVA), is often indistinguishable from that caused by obstructive epicardial CAD. The recent emergence of noninvasive techniques that can identify CMD, such as stress positron-emission tomography (PET) and cardiovascular magnetic resonance (CMR) myocardial perfusion imaging, allow improved identification of MVA. Using these tools, higher risk patients with MVA can be differentiated from those at lower risk in the heterogeneous population historically labeled as cardiac syndrome X. Likewise, MVA can be diagnosed in those with obstructive epicardial CAD who have persistent angina despite successful revascularization. There is little evidence to support current treatment strategies for MVA and current literature has not clearly defined CMD or whether therapy improves prognosis.
Related Concept Videos
Angina IV: Management
Angina V: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina I: Introduction
Acute Coronary Syndrome V: Nursing Management

